8307.1The Board may, in its discretion, approve continuing education programs that contribute to the growth of an applicant in professional competence in the practice of pharmaceutical detailing and which meet the other requirements of this section.
8307.2The Board may approve continuing education programs that meet the requirements of § 8307.3 and provide instruction in one of the following subjects:
(a) General medical and pharmaceutical terminology and abbreviations;(b) Food and Drug Administration laws and regulations pertaining to drug marketing, labeling, and clinical trials;(c) The cost-effectiveness of pharmacological treatments;(d) Therapeutic drug classes and categories;(f) Properties and actions of drugs and drug delivery mechanisms;(g) Etiologies, characteristics, and therapeutics of disease states;(i) The anatomical and physiological effect of pharmaceuticals.8307.3To qualify for approval by the Board, a continuing education program shall be an educational program given at a conference, a lecture, seminar, course of instruction, workshop, or on the Internet, and be prepared, offered, or administered by one of the following:
(a) A nationally or locally accredited program provider;(c) A health care facility;(d) A pharmaceutical company; or(e) An institution of higher learning recognized by an accrediting body approved by the Secretary of the United States Department of Education.8307.4The Board may issue a list of approved continuing education programs.
8307.5An applicant shall have the burden of verifying whether a program is approved by the Board pursuant to this section prior to attending the program.
8307.6The Board may approve the following continuing education activities by an applicant:
(a) Serving as an instructor or speaker at a lecture, conference, seminar, workshop, course of instruction, or in-service training; and(b) Publication of an article or book review in a professional journal or bulletin or publication of a book or chapter in a book.D.C. Mun. Regs. tit. 17, r. 17-8307
Final Rulemaking published at 55 DCR 9317 (August 29, 2008)